UNIVERSIDADE FEDERAL DE MINAS GERAIS - UFMG

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 7248
 
  
 
C07K PEPTIDES 4132
 
  
 
B01J CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS, COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS 3106
 
  
 
B09C RECLAMATION OF CONTAMINATED SOIL 27
 
  
 
C02F TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE 253
 
  
 
A01K ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS147
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 148
 
  
 
B01D SEPARATION 1133
 
  
 
C01B NON-METALLIC ELEMENTS; COMPOUNDS THEREOF178
 
  
 
C04B LIME; MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS 167

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0250,533 Method and Apparatus for Eliminating Harmonic Components and Obtaining a Uniform Power Factor in Alternating Current-Direct Current and Direct Current-Alternating Current ConvertersSep 17, 15Aug 31, 17[H02J, H02M, H02P]
2016/0168,224 PROCESS FOR PREPARING AMPHIPHILIC PEPTIDE DERIVATIVESJun 11, 14Jun 16, 16[C07K]
2015/0306,035 PHARMACEUTICAL COMPOSITION CONTAINING CONVENTIONAL LIPOSOMES AND PROLONGED-CIRCULATION LIPOSOMES FOR THE TREATMENT OF VISCERAL LEISHMANIASISMar 11, 13Oct 29, 15[A61K]
2013/0277,603 PROCESS FOR PREPARATION, APPLICATION AND RECOVERY OF ABSORBENT MATERIAL FOR NONPOLAR COMPOUNDS OR MIXTURESJul 14, 11Oct 24, 13[B09C, B01J, C02F]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9724671 Ceramic materials for absorption of acidic gasesJan 05, 15Aug 08, 17[C01B, C04B, B01J, B01D]
9701880 Process for preparing absorbent material for apolar compounds or mixturesMay 29, 13Jul 11, 17[C09K, B09C, B01J, C02F]
9279004 Synthetic PnTx(19) peptide, pharmaceutical compositions and useAug 20, 13Mar 08, 16[A61K, C07K]
9139638 Mouse model of cholinergic dysfunction to evaluate cognitive enhancers and drugs that improve myastheniaAug 21, 07Sep 22, 15[C12N, A01K, C07K]
8968749 Vaccine composition and immunization methodMay 27, 14Mar 03, 15[A61K]
8575111 Pharmaceutical compositions and methods for treating erectile dysfunctionJan 24, 08Nov 05, 13[A61K, C07K]
8383162 PHα1B toxin, CDNA of PHα1B toxin gene, pharmaceutical composition containing PHα1B toxin, process for their production and productNov 21, 07Feb 26, 13[A61K, A61P]
7723304 Systems for delivery and release of angiotensin-(1-7)Nov 05, 02May 25, 10[A61K]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2014/0149,162 Methods for tacit knowledge management and for transferring and developing tacit knowledgeAbandonedJan 21, 14May 29, 14[G09B, G06Q]
2013/0142,819 LEISHMANICIDAL FORMULATION AND ITS USEAbandonedMay 11, 11Jun 06, 13[A61K]
2011/0236,467 METHOD FOR ERECTILE FUNCTION POTENTIATION BY PHARMACEUTICAL COMPOSITIONS COMPRISING TOXIN TX2-6 OF THE SPIDER PHONEUTRIA NIGRIVENTERAbandonedJan 30, 09Sep 29, 11[A61K, C07H, A61P, C07K]
2011/0125,422 METHOD AND DEVICE FOR MEASURING AND MONITORINGAbandonedSep 11, 08May 26, 11[G06F, G01R]
7858597 Preparation of formulations of angiotensin II AT1 receptors antagonists for the treatment of arterial hypertension, other cardiovascular illnesses and its complicationsExpiredApr 09, 02Dec 28, 10[A61K]
2010/0294,204 MEASUREMENT OF ANIMAL TEMPERAMENTAbandonedJul 08, 08Nov 25, 10[A01K]
2010/0158,995 SYSTEMS FOR DELIVERY AND RELEASE OF ANGIOTENSIN-(1-7)AbandonedMar 01, 10Jun 24, 10[A61K, A61P]
2009/0270,495 Inhibitors of Phosphodiesterase Types 1 To 5 Based on Dioclein, Floranol, and Analogs ThereofAbandonedMar 30, 06Oct 29, 09[A61K, A61P]
2009/0005,303 PROTEASES FROM CARICA HAVING MITOGENIC ACTIVITY AND THEIR METHODS OF USEAbandonedJul 16, 07Jan 01, 09[A61K, A61P]
2008/0312,129 Use of Mas G-Protein-Coupled Receptor Agonists and Antagonists, as Apoptotic-Activity Modulators for Study, Prevention and Treatment of DiseasesAbandonedJun 28, 06Dec 18, 08[A61K, A61P]
2008/0058,284 Pharmaceutical compositions of semicarbazones and/or thiosemicarbazones and/or their derivatives and products of these compositions and their uses as anticonvulsant, anti-nociceptive and anti-inflammatory agents, and in the angiogenic therapyAbandonedJul 30, 07Mar 06, 08[A61K, A61P]
2007/0292,830 Collection of models for facilitating the study of at least one of a biological subject, an anatomical organ and an anatomical organ system of a living beingAbandonedAug 20, 07Dec 20, 07[G09B]
2007/0275,360 Collection of Cytological and Histological Models of Human Embryonic and Fetal Development for Visually Impaired PersonsAbandonedOct 21, 04Nov 29, 07[G09B]
2007/0275,901 SYNTHESIS, MODIFICATION AND REDUCTION OF PRIMARY STRUCTURE OF HYPOTENSIVE PEPTIDES PRESENT IN SCORPION VENOM FOR OPTIMIZING THEIR USE AS A HYPOTENSIVE MEDICAMENTAbandonedMar 19, 07Nov 29, 07[A61K, A61P, C07K]
2003/0219,778 Method for the diagnosis, identification and characterization of M. tuberculosis and other mycobacteria by shift mobility assayAbandonedDec 30, 02Nov 27, 03[C12Q, C12P]
6596846 Method and composition for the diagnosis of equine infectious anemia virus disease by using the recombinant capsid protein virus (p26)ExpiredJan 16, 01Jul 22, 03[C07K]
6444442 Method of producing a recombinant non-glycosylated gp90 of equine infectious anemia virus (EIAV), and product thereofExpiredAug 29, 00Sep 03, 02[A61K, C12N, C07K]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.